Skites Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Skites Pharma Private Limited

Skites Pharma Private Limited, a active private limited company, was established on 16 March 2017 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24304MH2017PTC292537. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹5.94 Cr.

It upholds a compliant status. Employing 459 professional, Its leadership includes Samir Jayantilal Shah (Director), Rohan Mahesh Shah (Director), Mahesh Kantilal Shah (Director). Past directors included Hiroshi Yonenaga, Eishi Maekawa, Mahesh Kantilal Shah. It holds ₹79.92 Cr open charges and no settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flr-G, 15, Mehta Mahal, P L Khandke Marg Mathew Road, Opera House, Girgaon, Mumbai, Maharashtra, 400004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304MH2017PTC292537

  • Registration Number

    292537

  • Incorporation Date

    16 March 2017

  • Authorized Capital

    ₹7.00 Cr

  • Paid-Up Capital

    ₹5.94 Cr

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.00 Cr
  • Paid Up Capital ₹ 5.94 Cr
  • Company Age 9 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 79.92 Cr
  • Revenue Growth **** 39.55%
  • Profit Growth **** 0.50%
  • Ebitda **** 427.49%
  • Net Worth -13.56%
  • Total Assets **** 38.53%
Company report

Skites Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Skites Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Skites Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Samir Jayantilal Shah Director 16 Mar 2017 Current
Rohan Mahesh Shah Director 16 Mar 2017 Current
Mahesh Kantilal Shah Director 13 Feb 2018 Current
Yusuke Kumaki Director 27 Jun 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Jul 2021 Past
Pramod Abcsdd Director 27 Jun 2025 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Additional Director 21 Jul 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Skites Pharma.

Skites Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.55% increase. The company also saw a slight improvement in profitability, with a 0.5% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.56%.

Skites Pharma revenue growth over time
Skites Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 39.55%
*******
*******
*******
*******
Revenue from Operations
*******
 39.54%
*******
*******
*******
*******
Total Assets
*******
 38.53%
*******
*******
*******
*******
Profit or Loss
*******
 0.50%
*******
*******
*******
*******
Net Worth
*******
 -13.56%
*******
*******
*******
*******
EBITDA
*******
 427.49%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Skites Pharma?

In 2023, Skites Pharma had a promoter holding of 100.00%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹799,200,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 79.92 Cr
Latest Charge Details
Date Lender Amount Status
22 Jun 2018 Hdfc Bank Limited ₹79.92 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Skites Pharma?

Skites Pharma has a workforce of 459 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Skites Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skites Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Skites Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Skites Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    The activity Yusuke Kumaki was appointed as a Director was appointed as a Director on 27 Jun 2025 & has been associated with this company since 10 months 14 days . was completed.

  • Balance Sheet

    Progress on Skites Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 79.92 Cr registered on 22 Jun 2018 with Charge ID 100194077 was modified on 22 Jul 2022. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 79.92 Cr with Charge ID 100194077 was registered on 22 Jun 2018. was documented.

  • Director Appointment

    Mahesh Kantilal Shah was appointed as a Director was appointed as a Director on 13 Feb 2018 & has been associated with this company since 8 years 2 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Skites Pharma Private Limited?

The CIN of Skites Pharma Private Limited is U24304MH2017PTC292537.

Where is Skites Pharma Private Limited headquartered?

Skites Pharma Private Limited is headquartered at Flr-G, 15, Mehta Mahal, P L Khandke Marg Mathew Road, Opera House, Girgaon, Mumbai, Maharashtra, 400004.

When was Skites Pharma Private Limited incorporated?

Skites Pharma Private Limited was incorporated on 16 March 2017.

Who are the current directors of Skites Pharma Private Limited?

The current directors of Skites Pharma Private Limited are

What is the primary industry of Skites Pharma Private Limited?

The primary industry of Skites Pharma Private Limited is Trade.

Is Skites Pharma Private Limited a listed company?

Skites Pharma Private Limited is unlisted.

What is the capital structure of Skites Pharma Private Limited?

The authorized capital of Skites Pharma Private Limited is ₹7.00 Cr, and the paid-up capital is ₹5.94 Cr.

What is the compliance status of Skites Pharma Private Limited?

The compliance status of Skites Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available